We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Merck & Co., Inc. stands seventh on our list and recently ...

The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future ...

Merck opened a $1 billion facility at its North Carolina site last month to boost U.S. production. Merck to invest $1 billion in new Delaware plant to boost US manufacturing Skip to main content ...

Pipeline Depth: $50 Billion in Potential. While oncology contributes a significant part to Merck’s revenue, its top-selling drug will confront biosimilar challenges after 2028.Nevertheless ...